Your Good Partner in Biology Research

Human tumor necrosis factor-related apoptosis-inducing ligand receptor 4(TRAIL-R4) ELISA Kit

  • 中文名称:
    人肿瘤坏死因子相关凋亡诱导配体受体4(TRAIL-R4)酶联免疫试剂盒
  • 货号:
    CSB-E04749h
  • 规格:
    96T/48T
  • 价格:
    ¥3200/¥2500
  • 其他:

产品详情

  • 产品描述:
    人肿瘤坏死因子相关凋亡诱导配体受体4(TRAIL-R4)酶联免疫试剂盒(CSB-E04749h)为双抗夹心法ELISA试剂盒,定量检测血清、血浆、组织匀浆样本中的TNFRSF10D含量。TNFRSF10D是一个靶点。它在肿瘤免疫等领域有重要背景,可参与调节免疫细胞活性等过程。其研究机制方面,主要围绕它与配体相互作用、下游信号通路传导展开,影响细胞增殖、凋亡等,为相关疾病治疗研究提供了方向。试剂盒检测范围为0.156 ng/ml- 10 ng/ml,灵敏度为0.039 ng/ml。该产品适用于肿瘤生物学、免疫调控机制等基础研究领域,可用于评估细胞模型、动物实验或临床前研究中TRAIL-R4的表达动态,辅助探究其在肿瘤微环境中的作用或药物干预效果,例如化疗药物敏感性测试、凋亡信号通路研究等场景。本品仅用于科研,不用于临床诊断,产品具体参数及操作步骤详见产品说明书。
  • 别名:
    CD 264 ELISA Kit; CD264 ELISA Kit; DcR 2 ELISA Kit; DcR2 ELISA Kit; Decoy receptor 2 ELISA Kit; Decoy with truncated death domain ELISA Kit; OTTHUMP00000123528 ELISA Kit; TNF receptor related receptor for TRAIL ELISA Kit; TNF related apoptosis inducing ligand receptor 4 ELISA Kit; TNF-related apoptosis-inducing ligand receptor 4 ELISA Kit; TNFRSF 10D ELISA Kit; TNFRSF10D ELISA Kit; TR10D_HUMAN ELISA Kit; TRAIL R4 ELISA Kit; TRAIL receptor 4 ELISA Kit; TRAIL receptor with a truncated death domain ELISA Kit; TRAIL-R4 ELISA Kit; TRAILR4 ELISA Kit; TRUNDD ELISA Kit; Tumor necrosis factor receptor superfamily member 10D ELISA Kit; Tumor necrosis factor receptor superfamily; member 10d; decoy with truncated death domain ELISA Kit
  • 缩写:
  • Uniprot No.:
  • 种属:
    Homo sapiens (Human)
  • 样本类型:
    serum, plasma, tissue homogenates
  • 检测范围:
    0.156 ng/ml - 10 ng/ml
  • 灵敏度:
    0.039 ng/ml
  • 反应时间:
    1-5h
  • 样本体积:
    50-100ul
  • 检测波长:
    450 nm
  • 研究领域:
    Cell Biology
  • 测定原理:
    quantitative
  • 测定方法:
    Sandwich
  • 精密度:

    Intra-assay Precision (Precision within an assay): CV%<8%

    Three samples of known concentration were tested twenty times on one plate to assess.

    Inter-assay Precision (Precision between assays): CV%<10%

    Three samples of known concentration were tested in twenty assays to assess.

  • 线性度:

    To assess the linearity of the assay, samples were spiked with high concentrations of human TRAIL-R4 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

     

    Sample

    Serum(n=4)

    1:1

    Average %

    89

    Range %

    86-92

    1:2

    Average %

    95

    Range %

    91-99

    1:4

    Average %

    98

    Range %

    92-104

    1:8

    Average %

    92

    Range %

    82-95

  • 回收率:

    The recovery of human TRAIL-R4 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.

    Sample Type

    Average % Recovery

    Range

    Serum (n=5)

    95

    90-101

    EDTA plasma (n=4)

    107

    102-110

  • 标准曲线:

    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

    ng/ml

    OD1

    OD2

    Average

    Corrected

    10

    2.214

    2.323

    2.269

    2.112

    5

    1.597

    1.486

    1.542

    1.385

    2.5

    0.957

    0.886

    0.922

    0.765

    1.25

    0.547

    0.568

    0.558

    0.401

    0.625

    0.355

    0.366

    0.361

    0.204

    0.312

    0.281

    0.297

    0.289

    0.132

    0.156

    0.208

    0.214

    0.211

    0.054

    0

    0.156

    0.157

    0.157

     

  • 数据处理:
  • 货期:
    3-5 working days

产品评价

靶点详情

  • 功能:
    Receptor for the cytotoxic ligand TRAIL. Contains a truncated death domain and hence is not capable of inducing apoptosis but protects against TRAIL-mediated apoptosis. Reports are contradictory with regards to its ability to induce the NF-kappa-B pathway. According to PubMed:9382840, it cannot but according to PubMed:9430226, it can induce the NF-kappa-B pathway.
  • 基因功能参考文献:
    1. The high-dose hook effect was apparent during ELISA testing of uDcR2 in chronic kidney disease (CKD) patients, yet dilution of the urine samples neutralized this effect. However, the use of a four-fold dilution of urine for uDcR2/cre testing may eliminate the high-dose hook effect and make it possible to effectively monitor the severity of TII in CKD patients. PMID: 29879421
    2. results suggest that CD264 is a surface marker of cellular age for bone marrow-derived mesenchymal stem cells. PMID: 28962588
    3. Urinary DcR2 could potentially serve as a novel biomarker for tubulointerstitial injury and may reflect senescence of renal proximal tubular cells in diabetic nephropathy. PMID: 28356293
    4. Results identified epigenetic inactivation of TNFRSF10C and TNFRSF10D in majority of cervical cancer cases. PMID: 26542757
    5. membrane expression more common in endometrioid endometrial cancer than in normal endometrium PMID: 24649804
    6. This study identified TNFRSF10D DNA methylation status as an independent prognostic biomarker for relapse-free survival and overall mortality in non-metastatic melanoma patients. PMID: 25003639
    7. The membrane expression of the TRAIL receptors DR4, DR5, DcR1 and DcR2 is greater in normal endometrium than endometrioid adenocarcinoma (EAC). The level of the receptors in EAC is not dependent on grading and staging and does not predict survival. PMID: 23584885
    8. the results presented here claim for a relevant impact of aberrant methylation of decoy receptors in melanoma and allow to understand how the silencing of DcR1 and DcR2 is related to melanomagenesis. PMID: 24211571
    9. TRAIL receptor-4 expression profiles on T cells might be important in revelation of rheumatoid arthritis pathogenesis. PMID: 20799941
    10. ANT2 shRNA treatment sensitized MCF7, T47 D, and BT474 cells to TRAIL-induced apoptosis by up-regulating the expression of TRAIL death receptors 4 and 5 (DR4 and DR5) and down-regulating the TRAIL decoy receptor 2 (DcR2). PMID: 20875141
    11. these results demonstrated that hypoxia-inducible factor 1alpha played a crucial role in regulating the transcription of DcR2. PMID: 20018172
    12. Enhanced expression of DcR2 promotes peripheral blood eosinophil survival in the airways of allergic asthmatics following segmental antigen challenge. PMID: 12421985
    13. Cytotoxicity and apoptosis induced by TRAIL to beta-cell lines CM were inhibited competitively by soluble TRAIL receptors, R1, R2, R3 or R4. PMID: 12488957
    14. Respiratory syncytial virus infection strongly up-regulated the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its functional receptors death receptor 4 (DR4) and DR5. PMID: 12915532
    15. Our results demonstrate that DcR1 and DcR2 genes are frequently methylated in various tumor types and aberrant methylation was the cause for silencing of DcR1 and DcR2 expression. PMID: 14999791
    16. The DcR2 was found to have a truncated and non-functional death domain. PMID: 15538968
    17. CD8+ lymphocytes and NKT lymphocytes, but not CD4+ lymphocytes, express TRAIL-R4 PMID: 15919363
    18. Resistance to TRAIL-induced apoptosis in acute myeloid leukemia cells is associated with expression of TRAIL-R4. PMID: 15921376
    19. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. PMID: 16319225
    20. DCR2 was found positive in 81 and 33% normal, 46 and 10% nodular hyperplasia, 74 and 36% PIN tissues, 87 and 89% low-grade carcinomas, and 100 and 93% high-grade carcinomas PMID: 16799475
    21. TRAIL-R4-beta is a new splice variant of TRAIL-receptor 4 lacking the cysteine rich domain 1 PMID: 16934748
    22. The specificity of DcR1- and DcR2-mediated TRAIL inhibition reveals an additional level of complexity for the regulation of TRAIL signaling. PMID: 16980609
    23. CASP8, DCR2, and HIN-1 methylation leads to progression of neuroblastoma PMID: 17545522
    24. These data strongly support a recent proposal that a segment at 8p21.3 contains crucial prostate cancer tumor suppressors. PMID: 18460741
    25. DCR2-methylated patients showed significantly poorer 5-year event-free survival in the whole neuroblastoma group (43% PMID: 18980997
    26. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients. PMID: 18981952
    27. Results indicate that disc cells, after herniation, undergo apoptotic cell death via the DR5/TRAIL pathway. PMID: 19730199

    显示更多

    收起更多

  • 亚细胞定位:
    Membrane; Single-pass type I membrane protein.
  • 组织特异性:
    Widely expressed, in particular in fetal kidney, lung and liver, and in adult testis and liver. Also expressed in peripheral blood leukocytes, colon and small intestine, ovary, prostate, thymus, spleen, pancreas, kidney, lung, placenta and heart.
  • 数据库链接:

    HGNC: 11907

    OMIM: 603614

    KEGG: hsa:8793

    STRING: 9606.ENSP00000310263

    UniGene: Hs.213467